Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

First Edition

Research Article February 28 2025
Estrogen Receptor Βeta Stimulation as a Possible Novel Therapeutic Target for Cutaneous T-Cell Lymphoma
Research Article February 28 2025
BCL11A-deficient human erythropoiesis is impaired in vitro and after xenotransplantation into mice
Research Article February 26 2025
Characterization and Treatment Outcomes of Malignant Histiocytoses in a Retrospective Series of 141 Cases in France
Research Article February 24 2025
Changes in Acute Care Use among People with Sickle Cell Disease after Adoption of a Prescription Drug Monitoring Program
Review Article February 24 2025
A roadmap for uniform comprehensive long- term follow up after curative therapy for sickle cell disease
Letter February 24 2025
Gastrointestinal toxicity of Gemtuzumab Ozogamicin: Real-life data from the AMLCG, SAL and CELL study groups
Research Article February 24 2025
Nilotinib attenuates vascular pathology in experimental cerebral malaria
Research Article February 21 2025
Improved survival with model-based dosing of anti-thymocyte globulin in pediatric hematopoietic cell transplantation
Research Article February 21 2025
Rituximab for children with EBV-positive Burkitt lymphoma in East Africa
Research Article February 21 2025
Outcomes of the COVID-19 pandemic in chronic lymphocytic leukemia: Focus on the very early period and Omicron era
Letter February 21 2025
BR or R-CHOP induction with rituximab maintenance in untreated, transplant-ineligible patients with mantle cell lymphoma
Letter February 21 2025
Cytogenetic annotation automation in myelodysplastic syndromes research databases
Letter February 20 2025
Diffuse Lung Involvement as a Rare Presentation of Systemic AL Amyloidosis: A Retrospective Cohort Study
Review Article February 19 2025
Implementing ASH's Guidelines for Acute Medical Care for Children and Adults with Sickle Cell Disease in Custody
Research Article February 19 2025
Presentation of CXCL12γ by heparan sulfate proteoglycans activates CXCR4 without desensitization in B cells
Letter February 19 2025
ATM inhibition decreases ERK activation and is synergistic with ibrutinib in primary chronic lymphocytic leukemia cells
Research Article February 19 2025
Improved Outcome and Therapeutic Directions in Pediatric Therapy-related AML: Recommendations by the AML-BFM Study Group
Letter February 19 2025
Long-Term Outcomes and Quality of Life with Treosulfan-Based Conditioning in Hematological Malignancies
Letter February 19 2025
Assessing AML-based risk criteria in patients with accelerated/blast-phase MPN treated with less-intensive therapy
Research Article February 14 2025
Phase 1 trial of durvalumab (anti-PD-L1) combined with lenalidomide in relapsed/refractory cutaneous T cell lymphoma
Research Article February 14 2025
In Vitro Studies of Human Erythropoiesis Using a 3D Silk-Based Bone Marrow Model That Generates Erythroblastic Islands
Research Article February 12 2025
Late-Onset Telomere Biology Disorders: Clinical Insights and Treatment Outcomes from a Retrospective Registry Cohort
Research Article February 12 2025
Mitigating T-Cell Mitochondrial Dysfunction in CLL to Augment CAR T-Cell Therapy: Evaluation in an Immunocompetent Model
Letter February 12 2025
The Differential Expression of Circulating MicroRNAs in Sickle Cell Trait compared to the Normal Hemoglobin Phenotype.
Research Article February 10 2025
Protection of CD33-modified hematopoietic stem cell progeny from CD33-directed CAR T cells in nonhuman primates
Research Article February 6 2025
Acute obstetric coagulopathy is associated with excess plasmin generation and proteolysis of fibrinogen and factor V
Review Article February 6 2025
FITNESS ASSESSMENT IN ACUTE MYELOID LEUKEMIA: RECOMMENDATIONS FROM AN EXPERT PANEL ON BEHALF OF EUROPEAN LEUKEMIA NET
Letter February 6 2025
A Novel Mouse Model to Study the Effects of New Therapies for Diamond Blackfan Anemia
Letter February 6 2025
GVHD in the era of checkpoint inhibition in Hodgkin Lymphoma
Research Article February 5 2025
Mosunetuzumab plus Pola-CHP compared with Pola-R-CHP in previously untreated DLBCL: final results from a Phase II study
Research Article February 5 2025
Intermediate-Dose Post-Transplantation Cyclophosphamide for Myeloablative HLA-Haploidentical Bone Marrow Transplantation
Letter February 5 2025
What to do with the WEIGHT while preparing for CAR-T?
Research Article February 5 2025
Glucagon-Like Peptide 1 Receptor Agonists and Venous Thromboembolism in Type 2 Diabetes: A Target Trial Emulation
Letter February 5 2025
Immune-aging is linked to clinical malignancy, racial ancestry and vaccine responses in myeloma
Research Article February 4 2025
CD19.CAR-T cell-derived extracellular vesicles express CAR and kill leukemic cells, contributing to antineoplastic therapy
Letter February 4 2025
Estimating rare genetic disease prevalence: a challenging task
Research Article January 30 2025
Impact of Vein-to-vein Time in Patients With R/R LBCL Treated With Axicabtagene Ciloleucel
Research Article January 28 2025
Outcome of high-grade B-cell lymphoma compared to other large B-cell lymphoma after CAR-T rescue. A DESCAR-T LYSA study
Research Article January 24 2025
Cutaneous dysbiosis characterizes the post-allogeneic hematopoietic stem cell transplantation period
Research Article January 24 2025
TP53 Mutant Variant Allele Frequency and Cytogenetics Determine Prognostic Groups in MDS/AML for Transplantation
Research Article January 18 2025
PRMT5 Inhibition Reduces Hyperinflammation in a Murine Model of Secondary Hemophagocytic Lymphohistiocytosis (HLH)
Research Article January 18 2025
Definitions and use of tumour bulk in phase 3 lymphoma trials: a comprehensive literature review
Research Article January 16 2025
TP53 Mutations are Associated with CD19 Negative Relapse and Inferior Outcomes after Blinatumomab in Adults with ALL
Review Article January 15 2025
Current developments in T-cell receptor therapy for Acute Myeloid Leukaemia
Research Article January 14 2025
Impacts of donor age and HLA mismatch on HCT outcomes differ according to the donor CMV serostatus in unrelated allo-HCT
Research Article January 7 2025
Maximum Tumor Diameter is Associated with Relapse Risk in Limited-Stage Hodgkin Lymphoma: An International Study
Research Article December 11 2024
Safety and Efficacy of Glofitamab for Relapsed/Refractory Large B-Cell Lymphoma in a Multinational Real-World Study
Page 3 of 3
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals